Endeavor Private Wealth Inc. raised its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 6.0% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,681 shares of the company’s stock after purchasing an additional 209 shares during the quarter. Endeavor Private Wealth Inc.’s holdings in Procter & Gamble were worth $586,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Nova Wealth Management Inc. bought a new stake in shares of Procter & Gamble during the 1st quarter worth $26,000. Signature Resources Capital Management LLC boosted its stake in shares of Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after acquiring an additional 72 shares in the last quarter. Quarry LP bought a new stake in shares of Procter & Gamble during the 1st quarter worth $33,000. Mizuho Securities Co. Ltd. boosted its stake in shares of Procter & Gamble by 566.7% during the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock worth $34,000 after acquiring an additional 170 shares in the last quarter. Finally, RMG Wealth Management LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter worth $37,000. 65.77% of the stock is owned by institutional investors.
Insider Buying and Selling at Procter & Gamble
In related news, CEO Jon R. Moeller sold 11,684 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the completion of the sale, the chief executive officer directly owned 319,932 shares in the company, valued at approximately $48,703,248.36. This trade represents a 3.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $606,788.78. Following the sale, the chief operating officer owned 46,899 shares of the company’s stock, valued at approximately $7,139,434.77. This represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock valued at $23,421,279 in the last quarter. Corporate insiders own 0.20% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same period last year, the company earned $1.40 earnings per share. Procter & Gamble’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Analysts Set New Price Targets
PG has been the subject of several research reports. Wells Fargo & Company reduced their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. BNP Paribas reissued an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. Berenberg Bank increased their target price on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. Evercore ISI restated an “in-line” rating and issued a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Finally, BNP Paribas Exane reduced their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a report on Tuesday, September 23rd. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $172.21.
Read Our Latest Research Report on PG
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- 3 Warren Buffett Stocks to Buy Now
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- Expert Stock Trading Psychology Tips
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.